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Background: The Kii peninsula of Japan is one of the foci of amyotrophic lateral sclerosis and parkinsonism-dementia
complex (ALS/PDC) in the world. The purpose of this study is to clarify the neuropsychological features of the patients
with ALS/PDC of the Kii peninsula (Kii ALS/PDC).
Methods: The medical interview was done on 13 patients with Kii ALS/PDC, 12 patients with Alzheimer’s disease,
10 patients with progressive supranuclear palsy, 10 patients with frontotemporal lobar degeneration and 10 patients
with dementia with Lewy bodies. These patients and their carer/spouse were asked to report any history of abulia-apathy,
hallucination, personality change and other variety of symptoms. Patients also underwent brain magnetic resonance
imaging (MRI), single photon emission computed tomography (SPECT), and neuropsychological tests comprising the
Mini Mental State Examination, Raven’s Colored Progressive Matrices, verbal fluency, and Paired-Associate Word Learning
Test and some of them were assessed with the Frontal Assessment Battery (FAB).
Results: All patients with Kii ALS/PDC had cognitive dysfunction including abulia-apathy, bradyphrenia, hallucination,
decrease of extraversion, disorientation, and delayed reaction time. Brain MRI showed atrophy of the frontal and/or
temporal lobes, and SPECT revealed a decrease in cerebral blood flow of the frontal and/or temporal lobes in all
patients with Kii ALS/PDC. Disorientation, difficulty in word recall, delayed reaction time, and low FAB score were
recognized in Kii ALS/PDC patients with cognitive dysfunction.
Conclusions: The core neuropsychological features of the patients with Kii ALS/PDC were characterized by marked
abulia-apathy, bradyphrenia, and hallucination.
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The Muro district covers the mountainous areas of the
southern coast of the Kii peninsula in Japan. Amyo-
trophic lateral sclerosis and parkinsonism-dementia
complex (ALS/PDC) endemic to residents in this area is
referred to as “Muro disease”. An epidemiological survey
of the prevalence rates of amyotrophic lateral sclerosis
(ALS) conducted in this area in the 1950s found very
dense accumulation in two villages in particular, Hohara
and Kozagawa. The prevalence rates in these villages
were approximately 100 times those in other areas of* Correspondence: kokubo-y@clin.medic.mie-u.ac.jp
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unless otherwise stated.Japan. Neuropathological features of ALS patients in this
area (Kii ALS) were similar to those observed in the
Chamorro people of Guam [1], and were characterized
by a combination of neurofibrillary tangles (NFTs) in
the brain and the changes of ALS [2]. Parkinsonism-
dementia complex (PDC) is characterized clinically by
progressive parkinsonism and dementia. This disorder is
frequently superimposed with ALS clinically and neu-
ronal loss with abundant NFTs in the temporal lobe,
frontal lobe and brainstem without accompanying senile
plaques was neuropathological hallmark [3,4].
Neuroradiological study with Kii ALS/PDC showed
hypometabolism of frontotemporal lobes, with or with-
out frontotemporal atrophy, resembling that of the
frontotemporal lobar degeneration (FTLD), but differentLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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radiological study of Kii ALS/PDS was similar to FTLD,
it is uncertain whether clinical features, especially in the
characteristics of dementia, of Kii ALS/PDC are same as
that of FTLD. Previous reports showed the clinical
characteristics of Kii ALS/PDC were abulia and amnesia
[6]. In the present study, we revealed abulia-apathy,
hallucination, impairment of orientation, deterioration of
recent memory and/or frontal executive dysfunction and
bradyphreniaof patients with Kii ALS/PDC compared
with patients with other types of dementia disorders,
and used brain magnetic resonance imaging (MRI) and
brain regional perfusion as assessed by single photon
emission computed tomography (SPECT) to reveal the
structural and functional abnormality linked to cognitive
dysfunction in these patients.Methods
Subjects
Thirteen patients with Kii ALS/PDC, 12 patients with
AD, 10 patients with progressive supranuclear palsy
(PSP), 10 patients with FTLD (behavior variant fronto-
temporal dementia type), and 10 patients with dementia
with Lewy bodies (DLB) were enrolled in this study. The
diagnosis of Kii ALS was made according to revised El
Escorial [7] criteria since the clinical symptoms of Kii
ALS are essentially the same as those of classical ALS
and genetic tests excluded other types of ALS with geneTable 1 Summary of neuropsychological and neuroimaging d
Patient
no.








1 64 M Kii-ALS Clinical F F, T
2 69 F Kii-ALS Clinical T F, T
3 68 M Kii-PDC Clinical T T, P
4 64 F Kii-ALS/PDC Clinical F, T F, T
5 66 F Kii-PDC Clinical T T, P
6 75 F Kii-PDC Clinical T F, T
7 76 F Kii-PDC Clinical F, T F, T
8 72 M Kii-PDC Autopsy F, T F, T
9 73 M Kii-PDC Clinical F, T, P F, T, P
10 76 M Kii-ALS/PDC Clinical F, T F, T
11 64 M Kii-PDC Clinical F, T, P F, T, P
12 68 F Kii-PDC Clinical F, T F, T
13 69 F Kii-PDC Clinical F F, P
Abbreviations: MRI magnetic resonance imaging, SPECT single-photon emission com
Colored Progressive Matrices, PAWLT Paired-Associate Word Learning test, FAB the F
(−), absent/unremarkable.mutation. The diagnosis of Kii PDC was made by a
unique combination of levodopa-unresponsive parkin-
sonism and dementia, which are frequently accompanied
by amyotrophy of the extremities [8]. Diagnosis of
patients with AD, PSP and DLB was “probable” accor-
ding to established diagnostic criteria [9-11], and the
patients with FTLD were diagnosed by established diag-
nostic criteria [12]. One of 13 patients with Kii ALS/
PDC was definitely diagnosed by autopsy [13]. Eleven of
Kii ALS/PDC had moderate to severe parkinsonism with
Hoehn-Yahr stage 3 to 5, and all of them were natives of
Hohara village and its vicinity.
This study was approved by the ethics committee of
the Mie University Hospital, Tsu, Mie, Japan. Written
informed consent was obtained from all patients or their
families prior to the study. The patients or next of kin
provided written informed consent for the publication of
individual clinical details as found in the descriptions of
individual cases and Table 1.Inquiry to the carer/spouse and neuroimaging
Patients and their carer/spouse were asked to report any
history of abulia-apathy, hallucination, personality changes
(extraversion, neuroticism, openness to experience, agree-
ableness and conscientiousness), inappropriate social
behavior/disinhibition, loss of empathy, loss of insight and
abnormal eating behavior. The carers/spouses were not














23 15 8 26 10 5 7 Not done
22 25 7 14 5 1 5 10
18 21 17 14 6 2 1 5
12 20 16 26 10 4 2 Not done
25 28 17 53 10 5 10 12
25 21 12 30 11 5 6 13
13 18 17 04 3 2 2 3
13 13 6 36 6 2 2 2
12 5 11 37 7 2 2 Not done
14 10 47 00 2 1 5 Not done
16 24 7 24 7 5 3 12
20 20 10 20 6 6 3 5
17 17 18 20 8 7 5 0
puted tomography, MMSE the Mini Mental State Examination, RCPM Raven’s
rontal Assessment Battery, F frontal lobe, T temporal lobe, P parietal lobe,
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ation, and were asked their impression regarding the pa-
tients. Any assessment instruments or quantitative scores
were not used. We defined apathy as a disorder of motiv-
ation, and operationalized as diminished goal oriented be-
havior and cognition. In addition, we considered abulia as
more severe type of apathy [14].
Neuroimaging studies of the head with magnetic res-
onance imaging (MRI) and angiography (MRA), and
brain regional perfusion as assessed by single photon
emission computed tomography (SPECT) were per-
formed for all patients. All MRI studies were performed
on either 0.5-T or 1.5-T units (FLEXART 0.5 T; Toshiba,
Tokyo, Japan and Signa 1.5 T; GE Medical Systems,
Milwaukee, WI). T1-and T2-weightedimages and fluid
fluid-attenuated inversion recovery were obtained. We
also used a SPECT scanner (model GCA-901A; Toshiba,
Otawara, Tochigi, Japan) with a tracer technetium Tc99m
ethyl cysteinate dimmer. The entire images were evaluated
visually by several experienced neuroradiologists by blind
manner. Statistical analysis was not done.
Neuropsychological tests
All patients underwent a standard cognitive status
assessment. ALS/PDC clinically show amnesia and bra-
dyphrenia, therefore we chose Mini Mental State Exam-
ination (MMSE) [15] for global cognition, Raven’s
Colored Progressive Matrices (RCPM) [16] for psycho-
motor speed, verbal fluency for frontal lobe function, the
Paired-Associate Word Learning test (PAWLT) [17] for
short-term memory and the Frontal Assessment Battery
(FAB) [18] for the frontal lobe function as battery. The
Standard Language Test of Aphasia (SLTA) [19] was
used to evaluate language function and aphasia. Each pa-
tient underwent all neuropsychological tests on the same
day. The Japanese version of the MMSE was used for
overall assessment of cognition [15], and we compared
the following: orientation (10 points), registration (3
points), attention and calculation (5 points), recall (3
points), and language and praxis (9 points). RCPM [16]
was used to assess current intellectual function and psy-
chomotor speed by measuring the time taken to perform
a task. Although the motor impairment of the upper
limb or dysarthria due to parkinsonism or ALS may
affect the results of RCPM, in that case, we asked the
patients to answer the number in oral, not by pointing
at the number, or assisted them physically to avoid the
effect of motor impairment to the utmost. To evaluate
verbal fluency as a measure of language function, we
asked patients to name as many items from a semantic
category (animals) and a letter category (words begin-
ning, representing Japanese mora) as possible for 1 mi-
nute. The lower limit of normal was set between 8 and
10 [20]. Short-term memory function was assessed byPAWLT. During this test, 10 word pairs were read to the
patient in three trials, and the first of each pair was then
presented for the patient to give the associated word
[17]. Several patients were assessed with FAB [20]. All
patients were checked for aphasia by a speech therapist,
and we diagnosed the subtypes of aphasia according to
the SLTA [19].
Statistical analyses
The data are reported as mean ± SEM (standard error
of the mean). All parameters were evaluated with
Mann–Whitney U. The SPSS 22 software package was
used to perform descriptive statistical analysis. Differences
were considered significant when the p value was < 0.05.
Results
Representative cases
Case 2 (Kii ALS with dementia)
The patient was a 69-year-old woman born in the Kii
peninsula with no family history of neurological diseases
and no history of major illness. She presented initially
with forgetfulness and reduced spontaneous motor and
emotional behavior at age 67 years. The following year,
she gradually developed dysarthria. At 69 years when
she was admitted to our hospital, she presented with
abulia-apathy, atrophy and fasciculation of the tongue,
dysarthria, limb muscle atrophy, increased deep tendon
reflexes and positive Babinski sign. Electromyography
disclosed ongoing denervation muscle potentials in the
biceps, the triceps, sternoclenocleidomastoideus, and the
gastrocnemius. Her diagnosis was clinically definite ALS
(revised El Escorial criteria [7]) at the time of admission.
Her Score of the revised ALS Functional Rating Scale
[21] was 34. Her MMSE score was 22 points, RCPM was
25 points and examination time was 7 minutes 14 seconds,
verbal fluency was 5 (animal) and 1 (letter), PAWLT was 5
and FAB was10 points. SLTA did not present any aphasia
detail as follows; auditory comprehension (9 of 10); spon-
taneous speech (5 of 6); naming (20 of 20); sentence repeti-
tion (5 of 5); kana word reading aloud (5 of 5); kanji word
reading aloud (5 of 5); reading aloud short sentences (5 of
5); kana word comprehension (10 of 10); kanji word com-
prehension (9 of 10); reading comprehension (9 of 10);
dictation of kana letters (10 of 10); dictation of kana words
(5 of 5); dictation of kanji words (5 of 5) and dictation of
short sentences (4 of 5). MRI scans revealed atrophy of the
temporal lobes and SPECT images revealed a decline in
cerebral blood flow in the temporal lobes. The clinical diag-
nosis was probable Kii ALS with dementia.
Case 8 (Kii PDC)
The patient was a 72-year-old man who was born in
Hohara and had a history of hypertension. He had no
family history about the neurodegenerative diseases. He
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nesia at 68 years. His parkinsonian symptoms of resting
tremor and clumsy hands worsened progressively. At the
age of 72 he suffered from visual hallucinations. After
that, his verbal, motor and emotional behavior gradually
became less spontaneous, and he was admitted to our
hospital. Neurological examination at admission revealed
parkinsonism with rigidity, bradykinesia, and postural in-
stability, and dementia characterized by amnesia, abulia-
apathy and bradyphrenia. His Hoehn Yahr scale was 5 [22].
MMSE score was 13 points, RCPM was 13 points and
examination time was 6 minutes 36 seconds, verbal fluency
was 6, PAWLT was 2. MRI scans revealed atrophy of
frontal and temporal lobes and SPECT images revealed a
decline in cerebral blood flow in the same lobes. When he
died of pneumonia at age 74, an autopsy was performed
after obtaining informed consent from his family. The
formalin-fixed brain specimen weighed 1255 g., Gross in-
spection showed moderate atrophy of the hippocampus
and striatum, severe depigmentation of the substantia nigra
and locus coeruleus Microscopically, there were severe
neuronal loss and many neurofibrillary tangles in the me-
dial temporal lobe, nuclei of the brainstem, amygdala and
nucleus of Mynert, and moderate neuronal loss of the an-
terior horn cells. Moderate α-synuclein pathology coexisted
mainly in the nuclei of the brainstem. Neuropathological
diagnosis was Kii PDC [13].
Inquiry to the carer/spouse and neuroimaging
Clinical data of each group are shown in Table 2. Although




Age at examination, y 69.5 ± 4.5
(58–78)
Duration of the disorder, y 4.9 ± 1.6
Duration of the cognitive impairement, y 2.6 ± 1.1




Slowing of psychomotor speed 84
Personality changes 77
Decrease of extraversion 77
Alteration of personarity 0
Inapproriate social behavior/disinhibition 0
Aphasia 0
*P < 0.05 compared with Kii ALS/PDC patients. Abbreviations: ALS amyotrophic latera
PSP progressive supranuclear palsy, FTLD frontotemporal lobar degeneration, DLB dwas no significant difference in the duration of the cogni-
tive impairment and education for Kii ALS/PDC, AD, PSP,
and FTLD. Neuropsychological deficits developed in vari-
ous time course in each patient. In some patients, neuro-
psychological deficits developed prior to motor symptoms,
in other motor symptoms preceded neuropsychological
deficits. The duration of disorder of patients with Kii ALS/
PDC was longer than the patients with AD, PSP and FTLD.
Abulia-apathy was prominent and present in 62% of Kii
ALS/PDC patients. Among personality changes (extraver-
sion, neuroticism, openness to experience, agreeableness
and conscientiousness), inappropriate social behavior/disin-
hibition, loss of empathy, loss of insight and abnormal eat-
ing behavior, only decrease of extraversion was observed in
Kii ALS/PDC. Hallucinations of the patients with Kii ALS/
PDC were about well-formed complex vivid images of
human faces or animals in the absence of the visual stimu-
lates. Brain MRI showed atrophy of the frontal and/or tem-
poral lobes, and SPECT revealed a decrease in cerebral
blood flow of the frontal and/or temporal lobes in all
patients with Kii ALS/PDC (Table 1). The results of neuro-
imaging tests are shown in Table 3.
Neuropsychological tests
The neuropsychological data of patients with Kii ALS/
PDC are shown in Table 1 and that of each type of
dementia are shown in Table 4. A significant difference
in MMSE total scores was found between patients with
Kii ALS/PDC and patients with AD and PSP despite the
equivalent duration of the cognitive impairment in each









4/8 6/4 4/6 4/6
67.3 ± 5.4 71.3 ± 4.8 66.3 ± 9.0 68.9 ± 5.3
(60–75) (63–79) (58–84) (60–75)
2.5 ± 0.4* 2.0 ± 1.5* 2.4 ± 1.4* 3.3 ± 1.2
2.5 ± 0.4 2.0 ± 1.5 2.1 ± 1.2 2.4 ± 1.1
11.6 ± 3.2 10.7 ± 3.2 11.0 ± 2.6 11.5 ± 2.6
0* 0* 0* 80*
0* 50 30 30
42 70 20* 70
58 80 80 60
50 80 80 60
17* 10 70* 10
8 0 30* 0
0 0 30* 0
l sclerosis, PDC parkinsonism-dementia complex, AD Alzheimer’s disease,
ementia with Lewy bodies.











MRI brain atrophy (%)
Frontal 69.2 8.3 60.0 60.0 30.0
Temporal 84.6 58.3 0.0 80.0 0.0
Parietal 15.3 75.0 0.0 0.0 10.0
Occipital 0.0 0.0 0.0 0.0 0.0
SPECT decrease of cerebral blood flow (%)
Frontal 84.6 16.7 80.0 90.0 30.0
Temporal 92.3 72.7 10.0 90.0 0.0
Parietal 30.7 83.3 0.0 20.0 70.0
Occipital 0.0 8.3 0.0 10.0 60.0
Abbreviations: MRI magnetic resonance imaging, SPECT single-photon emission computed tomography.
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AD and FTLD patients, and in their recall score compared
with PSP and FTLD patients. Nor was there significant
difference in the RCPM total score of each patient group,
but patients with Kii ALS/PDC took significantly longer
time to perform tasks than patients with AD and FTLD.
Although the results of the verbal fluency test about a
semantic category showed no significant difference
between patient groups, there was a significant difference
about in a letter category between Kii ALS/PDC and AD.
The results of the PAWLT score was significantly lower in
Kii ALS/PDC than in PSP patients. Although we exa-





MMSE total score (/30) 19.2 ± 6.4 22.7 ± 1.2
Orientation (/10) 5.8 ± 3.3 7.9 ± 0.6*
Registration (/3) 2.9 ± 0.3 3.0 ± 0.0
Attention and calculation (/5) 1.8 ± 1.9 2.1 ± 1.5
Recall (/3) 0.6 ± 0.9 1.1 ± 0.7
Language and praxis (/9) 7.9 ± 1.2 8.2 ± 1.1
RCPM
Total score (/36) 19.3 ± 6.8 22.3 ± 6.2
Time (min sec) 14 37 ± 10 19 9 45 ±5 1
Verbal fluency
Semantic category 7.6 ± 3.2 8.5 ± 2.7
Letter category 3.6 ± 2.0 6.9 ± 2.1*
PAWLT (/10) 5.0 ± 3.2 5.4 ± 1.9
FAB (/18) 8.0 ± 5.5 13.9 ± 6.0
(9 of 13 patients) (8 of 12)
*p < 0.05, compared with Kii ALS/PDC patients.scores of the patients with Kii ALS/PDC were worse than
those of patients with AD.
Discussion
The present study revealed that the core neuropsycho-
logical symptoms of patients with Kii ALS/PDC were
abulia-apathy, hallucination, impairment of orientation,
deterioration of recent memory and/or frontal executive
dysfunction and bradyphrenia.
AD is a progressive neurodegenerative disorder that is
characterized by the presence of amyloid deposits and
NFTs together with the loss of cortical neurons and







* 23.2 ± 2.5* 22.0 ± 4.5 20.7 ± 1.3
8.0 ± 1.8 8.0 ± 0.6* 6.8 ± 1.6
3.0 ± 0.0 3.0 ± 0.0 3.0 ± 0.0
1.6 ± 0.9 1.7 ± 1.4 1.5 ± 1.1
2.1 ± 1.0* 1.9 ± 0.9* 1.2 ± 1.1*
8.5 ± 1.1 7.9 ± 0.9 8.1 ± 1.1
21.2 ± 4.1 22.0 ± 4.4 19.3 ± 6.8
9* 12 56 ± 9 38 9 22 ± 3 51* 12 52 ± 6 39
6.4 ± 2.9 7.8 ± 3.2 9.1 ± 3.2
5.1 ± 2.6 4.5 ± 2.2 4.4 ± 1.7
7.1 ± 1.6* 6.0 ± 2.8 6.5 ± 3.5
* 12.0 ± 2.2 10.0 ± 2.2 12.3 ± 2.6
(4 of 10) (4 of 10) (3 of 10)
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the ability to recall events that are specific to a time and
place [24]. AD is characterized by deficits in attentional
and executive functions [25]. Depression is the main
psychiatric correlate of abulia-apathy in AD. Several
studies have demonstrated a significant association be-
tween apathy and reduction in metabolic activity of the
frontal lobes, and more severe parkinsonism suggesting
that neuropathological changes in specific brain areas
may underlie the high frequency of apathy in AD [26]. A
recent study has shown that apathy is a behavioral marker
of more aggressive dementia characterized by faster
progression of cognitive impairment [27]. Delusions, and
in particular paranoid delusions, are more common
than hallucinations in AD [28].
PSP is one of the most common atypical parkinsonian
syndromes. PSP pathology is characterized by the abnor-
mal accumulation of tau protein accompanied by neu-
ronal loss and gliosis, mainly in subcortical structures
[29]. The striato-frontal dysfunction leads to dramatic defi-
cits in planning, monitoring and recall, which evolves into
dementia in PSP patients [30,31]. The cognitive impairment
of PSP patients has been considered the archetype of
subcortical dementia. The striking features are severe
bradyphrenia, impaired verbal fluency, and difficulty with
sequential actions or shifting from one task to another [32].
Cognitive tests that depend on visual performance are espe-
cially affected. Dementia is less severe than might be sug-
gested by dysarthria, bradyphrenia, poor eye contact, and
loss of facial expression. Abulia-apathy and disinhibition
are common. Emotional incontinence is dominated by
inappropriate weeping or, less frequently, laughing.
FTLD is the third most common cause of cortical
dementia, following AD and DLB [12]. FTLD encom-
passes two major pathologic substrates that affect
primarily thefrontal or temporal cortex, in some patients
asymmetrically. Three prototypic neurobehavioral syn-
dromes can result from FTLD. The most common cli-
nical manifestations of FTLD are changes in character,
disordered social conduct, and lack of affect, concern
and insight, with relative preservation of memory func-
tion [33,34]. Cognitive deficits occur in the domains of
attention, abstraction, planning, and problem solving, in
keeping with a frontal dysexecutive syndrome, whereas
primary tools of language, perception, and spatial func-
tions are well preserved. Patients are not clinically
amnesic. Two other prototypic clinical syndromes occur
in FTLD: progressive non-fluent aphasia and semantic
dementia [33]. The disorder of language occurs in the
absence of impairment in other cognitive domains.
DLB was originally defined as a clinicopathologic entity
with a specific constellation of clinical features, and a
descriptive approach was proposed for assessing
neuropathology [9]. The only neuropathologic requirementfor DLB is the presence of Lewy bodies somewhere in the
brain of a patient with a clinical history of dementia. Recur-
rent, complex visual hallucinations continue to be one of
the most useful signposts to a clinical diagnosis of DLB.
Disability in DLB derives not only from cognitive im-
pairment but also from neuropsychiatric, motor, sleep,
and autonomic dysfunction. The cognitive profile of
DLB comprises both cortical and subcortical impair-
ments with substantial attentional deficits and promin-
ent executive and visuospatial dysfunction [35,36].
In this study, the clinical features of Kii ALS/PDC are
abulia-apathy and hallucination, but not alteration of
personality and aphasia. The patients with Kii ALS/PDC
share some part of symptoms with PSP and DLB pa-
tients. In MMSE and PAWLT, the patients with Kii
ALS/PDC showed more severe disorientation than those
with AD and FTLD, and more severe deterioration of
recent memory than those with PSP and FTLD despite
the equivalent duration of the cognitive impairment in
each group. Recall performance can potentially be im-
paired as a result of a primary amnesia, or secondarily as
a result of poor frontal executive function, therefore it
was difficult to discriminate a primary amnesia and poor
frontal executive function in the patients with Kii ALS/
PDC in this study. RCPM results revealed that the bra-
dyphrenia observed in Kii ALS/PDC patients was even
slower than that observed in AD patients and FTLD pa-
tients. Although the results of FAB, which was examined
only in several selected cases, showed the patients with
Kii ALS/PDC might have frontal executive dysfunction,
there was a limitation of the study in view of the central
importance of assessing frontal lobe functions in this
patient group.
Most characteristic cognitive deficit of Kii ALS/PDC
was abulia/apathy. Abulia/apathy may reflect neuronal
loss and tau pathology especially in the anterior cingu-
late gyrus in which the decrease of the cerebral blood
flow was also detected in SPECT (unpublished data).
Visual hallucination may be linked to α-synuclein path-
ology [37]. The patients with Kii ALS/PDC lacked the
typical symptoms of behavior variant FTD, semantic
dementia and non-fluent progressive aphasia, those were
personality change, inappropriate social behavior/
disinhibition, loss of empathy, loss of insight, abnormal
eating behavior and aphasia, except for decrease of extra-
version, apathy and reduced speech. Although Kii ALS/
PDC showed atrophy and the decrease of the blood flow in
the frontal lobe and temporal lobe, the neuropsychological
symptoms of patients with Kii ALS/PDC was different from
those of the patients with FTLD. Also Kii ALS/PDC
showed unique cognitive impairments comparing with AD,
PSP, FTLD and DLB.
This study has a limitation in that we could not evalu-
ate focus on frontal function except for FAB, none of
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the motor impairment due to parkinsonism or ALS may
affect the results of battery. There is a possibility of the
effect to the performance in the test. We have only small
cases of Kii ALS/PDC, and statistical comparison also
has a limitation. However, the results of clinical symp-
toms, neuropsychological tests and neuroradiological
tests seemed to be mutually related. These results are
expected to contribute something to solving Kii ALS/
PDC.
Conclusion
Cognitive impairment of Kii ALS/PDC patients is unique
frontal-subcortical and temporal-cortical dementia.
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